For Immediate Release <\/p>\n
Chicago, IL \u2013 June 17, 2026 \u2013 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Applied Materials, Inc. AMAT, GE Aerospace GE, AstraZeneca PLC AZN, Team, Inc. TISI and Applied Energetics, Inc. AERG.<\/p>\n
Here are highlights from Tuesday\u2019s Analyst Blog:<\/p>\n
Top Stock Picks for Applied Materials, GE & AstraZeneca<\/p>\n
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Applied Materials, Inc., GE Aerospace and AstraZeneca PLC, as well as two micro-cap stocks, Team, Inc. and Applied Energetics, Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.<\/p>\n
You can see all of today\u2019s research reports here >>><\/p>\n
Today’s Featured Research Reports<\/p>\n
Applied Materials\u2019\u00a0shares have outperformed the Zacks Electronics – Semiconductors industry over the past year (+236.5% vs. +100.4%). Per the Zacks analyst, the company is benefiting from AI-driven demand that is boosting spending on advanced semiconductor manufacturing and packaging technologies, where it holds strong market positions. New product innovations, deeper customer collaborations, and growing services adoption support pricing power and operational efficiency.<\/p>\n
Yet, risks include significant exposure to China amid evolving export restrictions, the cyclical nature of semiconductor capital spending, and intense competition across equipment categories. These factors could create demand volatility and pressure market share.<\/p>\n
(You can read the full research report on Applied Materials here >>>)<\/p>\n
GE\u2019s shares have outperformed the Aerospace – Defense industry over the past six months (+17.1% vs. -3.6%). The Zacks analyst believes that GE is benefiting from strong demand for commercial engines and advanced aerospace technologies, supported by healthy air travel trends and rising global defense spending. Portfolio optimization efforts also support long-term growth.<\/p>\n
Risks include elevated project and restructuring costs, supply-chain disruptions that may increase expenses and delays, and foreign-exchange headwinds from its global operations.<\/p>\n
(You can read the full research report on GE here >>>)<\/p>\n
AstraZeneca\u2019s shares have outperformed the Zacks Medical \u2013 Biomedical and Genetics industry over the past year (+24.9% vs. +15.0%). The Zacks analyst believes that the company is benefiting from strong demand for key medicines, a robust late-stage pipeline, and strategic acquisitions and collaborations that strengthen future growth. Investments in high-growth emerging markets and new product launches also support its long-term outlook.<\/p>\n
Story Continues <\/p>\n
However, looming patent expirations for several blockbuster drugs leads to increasing generic competition. Existing generic erosion is already affecting some products, while exclusivity losses for key medicines may pressure future sales growth.<\/p>\n
(You can read the full research report on AstraZeneca here >>>)<\/p>\n
Team\u2019s shares have outperformed the Zacks Building Products \u2013 Maintenance Service industry over the past two years (+115.0% vs. -4.0%). The Zacks analyst believes that the company is benefiting from steady demand for infrastructure maintenance and inspection services, supported by its integrated business model, improving operational execution, and margin-enhancing cost and pricing initiatives. Growth opportunities in key markets and renewed strategic focus also support its outlook.<\/p>\n
Yet, challenges include a highly leveraged balance sheet, elevated financing costs, and cash flow pressure that limit financial flexibility. Ongoing losses, uneven profitability, capital dilution, and exposure to legal and non-core expenses remain additional headwinds.<\/p>\n
(You can read the full research report on Team here >>>)<\/p>\n
Applied Energetics\u2019\u00a0shares have underperformed the Zacks Laser Systems and Components industry over the past year (-27.1% vs. +69.2%). The Zacks analyst believes that the company faces pressure from rising costs, persistent losses, cash burn, and dependence on volatile government-funded contracts. Additional risks include dilution, limited trading liquidity, supply-chain constraints, inflationary pressures, and potential project delays.<\/p>\n
However, the company continues to advance specialized technologies and development programs, which could support future contract opportunities and long-term growth if execution improves and funding visibility strengthens.<\/p>\n
(You can read the full research report on Applied Energetics here >>>)<\/p>\n
Free: Instant Access to Zacks’ Market-Crushing Strategies<\/p>\n
Since 2000, our top stock-picking strategies have blown away the S&P’s +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.<\/p>\n
Today you can tap into those powerful strategies \u2013 and the high-potential stocks they uncover \u2013 free. No strings attached.<\/p>\n
Get all the details here >><\/p>\n
support@zacks.com<\/p>\n
https:\/\/www.zacks.com<\/p>\n
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed\u00a0that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and\u00a0is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https:\/\/www.zacks.com\/performance\u00a0for information about the performance numbers displayed in this press release.<\/p>\n
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report<\/a><\/p>\n GE Aerospace (GE) : Free Stock Analysis Report<\/a><\/p>\n AstraZeneca PLC (AZN) : Free Stock Analysis Report<\/a><\/p>\n Applied Materials, Inc. (AMAT) : Free Stock Analysis Report<\/a><\/p>\n Team, Inc. (TISI) : Free Stock Analysis Report<\/a><\/p>\n Applied Energetics Inc. (AERG): Free Stock Analysis Report<\/a><\/p>\n This article originally published on Zacks Investment Research (zacks.com).<\/a><\/p>\n